The mutational constraint spectrum quantified from variation in 141,456 humans

Konrad J. Karczewski, Laurent C. Francioli, Grace Tiao, +172

Nature

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

Joanna M. Wardlaw, Eric E. Smith, Geert Jan Biessels, +33

The Lancet Neurology

Neuroimaging StandardsNeuroimaging BiomarkersNeurodegenerative DiseasesNeurological DisorderMedicine +10

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, +31

New England Journal of Medicine

A pathology atlas of the human cancer transcriptome

Mathias Uhlén, Cheng Zhang, Sunjae Lee, +24

Science

PathologyMultiomicsMetabolic RemodelingCancer BiologyTumor Biology +15

Pan-cancer analysis of whole genomes

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, +1293

Nature

EuroSCORE II

Samer A.M. Nashef, F. Roques, Linda Sharples, +4

European Journal of Cardio-Thoracic Surgery

Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest

Niklas Nielsen, Jørn Wetterslev, Tobias Cronberg, +30

New England Journal of Medicine

World Stroke Organization (WSO): Global Stroke Fact Sheet 2022

Valery L. Feigin, Michael Brainin, Bo Norrving, +6

International Journal of Stroke

Cerebrovascular DiseaseWorld Stroke OrganisationThrombosisStroke RehabilitationNeurology +21

An agenda for sustainability transitions research: State of the art and future directions

Jonathan Köhler, Frank W. Geels, Florian Kern, +26

Environmental Innovation and Societal Transitions

Public PolicyEngineeringGreen TransitionFuture DirectionsSustainability Governance +10

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

M. William Audeh, James Carmichael, Richard T. Penson, +12

The Lancet

MedicineCancer ManagementGynecologyRecurrent Ovarian CancerPolymerase Inhibitor Olaparib +5